Lupin partners with Sandoz for biosimilar ranibizumab commercialization. • Sandoz handles commercialization in multiple regions, excluding Germany. • Lupin will
Browsing: M&A and Licensing
News and insights on mergers, acquisitions, licensing deals, and strategic collaborations across the global pharma industry.